Curia India Private Limited - pharma in Hyderabad, Telangana, India. FY 2026 financials & compliance.
CIN U73200TG2005PTC045178 Incorporated 25 January 2005 ROC Hyderabad HQ Hyderabad, Telangana, India
Active Private Limited Company pharma
Data last updated
Revenue · FY 2025
₹282.6 Cr
▲ 23% YoY
Net profit · FY 2025
₹40.04 Cr
Net margin 14.2%
EBITDA · FY 2025
₹69.58 Cr
EBITDA margin 24.6%
Authorised capital
₹230.5 Cr
Registered with MCA
Paid-up capital
₹49.78 Cr
Issued & subscribed
Open charges
₹1.1 Cr
Secured borrowings
Company age
21 yrs
Est. 2005
Employees · EPFO
11
Provident fund records

About Curia India Private Limited

Data last updated:

Curia India Private Limited is a private limited company based in Hyderabad, Telangana, India, a subsidiary of Curia Global Holdings Limited, Uk (Formerly Albany Molecular Research Limited, Uk). It operates in the pharma contract r and d segment of the pharmaceuticals sector. It was incorporated on 25 January 2005 and has been in existence for over 21 years.

The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U73200TG2005PTC045178. Its GSTIN is 36AAFCA1469D1ZX (Telangana). The company holds 4 GST registrations, of which 3 are active.

The company has an authorised share capital of ₹230.5 Cr and a paid-up capital of ₹49.78 Cr. It was formerly known as Albany Molecular Research Hyderabad Research Centre Private Limited. It is led by directors including Murali Krishna Valluri (Whole-Time Director) and Manoj Deo Dorlikar (Whole-Time Director).

Its last annual general meeting (AGM) was held on 29 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at No: 9 Sy No: 230 – 243 Phase – I Mn Park Turkapally Shamirpet Mandal Genome Valley, Hyderabad, Telangana, India – 500078.

As per the financials filed for FY 2025, the company reported a revenue of ₹282.6 Cr, a growth of 23% compared to the previous year. For the same year it recorded a net profit of ₹40.04 Cr (net margin 14.2%) and EBITDA of ₹69.58 Cr (EBITDA margin 24.6%). Revenue has grown at a compounded annual rate (CAGR) of 2% over three years and 16% over five years.

The company has about 11 employees on its provident fund (EPFO) records.

The company is associated with 1 brand: Curia. As per MCA filings, the company has open charges of ₹1.1 Cr on record. Court records list 4 cases involving the company, including 1 filed by the company and 3 filed against it; 4 cases are pending. The company has 6 deals on record (4 funding rounds, 2 secondary share transfers), with disclosed funding of ₹25.61 Cr; the latest was in March 2017. The company has 13 MSME Form 1 returns on record between 2019 and 2023, listing 1,941 overdue payments to 136 micro and small suppliers.

The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website curiaglobal.com.

Company details

CIN U73200TG2005PTC045178
Registration Number 045178
Incorporation Date 25 January 2005
ROC Hyderabad
Listing Status Unlisted
Company Status Active
Date of Last AGM 29 September 2025
Date of Balance Sheet 31 March 2025
Parent Company Curia Global Holdings Limited, Uk (Formerly Albany Molecular Research Limited, Uk)
Compliance Status Active Compliant

CIN history

Curia India has one previous CIN (Corporate Identification Number): U73200AP2005PTC045178. The current CIN is U73200TG2005PTC045178, which is the unique identifier assigned by the Registrar of Companies.

CINStatus
U73200TG2005PTC045178Current
U73200AP2005PTC045178Previous

Contact details

Curia India Private Limited's registered office is in Hyderabad, Telangana. Its website is curiaglobal.com. Its e-mail address and telephone number are in the company report.

  • Email
  • Telephone
  • Social Media
  • Registered Address
    No: 9 Sy No: 230 – 243 Phase – I Mn Park Turkapally Shamirpet Mandal Genome Valley, Hyderabad, Telangana, India – 500078
  • Industry
    Pharma, Pharma Contract R&D

To see the full contact details of Curia India Private Limited, buy the company report.

Comprehensive company report
Curia India Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Brands

Curia India operates one associated brand: Curia. Each brand links to its own profile.

BrandDescriptionWebsite
Drug research, development, testing, and consulting services are provided.curiaglobal.com

Business activity

The main business activities of Curia India are professional, scientific and technical, manufacturing and information and communication. In detail, this covers scientific research and development, chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products and other information & communication service activities. 3 activity segments are registered with the MCA.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
MProfessional, Scientific and TechnicalM5Scientific research and development
CManufacturingC6Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products
JInformation and communicationJ8Other information & communication service activities

To see the full business activity and turnover split of Curia India Private Limited, buy the company report.

Financials of Curia India Private Limited

FY 2025 filings available

Curia India Private Limited reported revenue of ₹282.6 Cr (up 23% YoY) for FY 2025.

Revenue · FY 2025
₹282.6 Cr ▲ 23%
Net profit · FY 2025
₹40.04 Cr margin 14.2%
EBITDA · FY 2025
₹69.58 Cr margin 24.6%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▲ 23%
3 years · compounded
▲ 2%
5 years · compounded
▲ 16%
EBITDA CAGR growth
1 year
▲ 63%
3 years · compounded
▲ 9%
5 years · compounded
▲ 19%

Revenue has grown at a compounded annual rate (CAGR) of 16% over five years, including 23% growth in the latest year. EBITDA rose 63% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA₹69.58 Cr
Profit Before Tax
Tax Expense
Net Profit (PAT)₹40.04 Cr
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profitability
EBITDA Margin24.6%
Net Profit Margin14.2%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Curia India Private Limited, buy the company report.

Board of directors of Curia India Private Limited

Curia India has 5 current directors and 23 former directors. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Murali Krishna ValluriWhole-Time Director21 Dec 20169 Years 10 MonthsCurrent
James Francis Grabowski JrDirector15 Dec 20214 Years 10 MonthsCurrent
Mariesa Beth CoppolaDirector13 Dec 20178 Years 10 MonthsCurrent
Manoj Deo DorlikarWhole-Time Director12 Jul 20233 Years 3 MonthsCurrent
Satyanarayana TummanapalliWhole-Time Director18 Sep 20251 Years 1 MonthsCurrent

Auditor

Curia India Private Limited is audited by B S R and Co. for the financial year 2023.

Auditor firmFinancial yearFirm registration number
B S R and Co.FY 2023128510W

Shareholding

The shareholding of Curia India Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.

Shareholder categoryFY 2023FY 2022FY 2021FY 2020FY 2019
Promoters
Domestic institutional investors (DII)
Foreign institutional investors (FII)
Public
Others

To see the full shareholding pattern of Curia India Private Limited, buy the company report.

Charges & borrowings

Open charges
₹1.1 Cr
Satisfied charges
None
Breakdown by lending institutions
The Cosmos Co-Operative Bank Limited₹1.10 Cr
Latest charge details
DateCharge IDLenderAmountStatusModified or satisfied on
05 Jul 200490145269The Cosmos Co-Operative Bank Limited₹10 LakhOpen
08 Jun 200490145220The Cosmos Co-Operative Bank Limited₹15 LakhOpen
12 Apr 200490145123The Cosmos Co-Operative Bank Limited₹25 LakhOpen
08 Apr 200490149516The Cosmos Co-Operative Bank Limited₹60 LakhOpen

Total charge records: 4 View all charges

Deals & funding

Curia India Private Limited has 6 deals on record (4 funding rounds, 2 secondary share transfers), with disclosed funding of ₹25.61 Cr; the latest was in March 2017.

Total deals
6
Funding rounds
4
Secondary share transfers
2
Disclosed funding
₹25.61 Cr

Deals on record (5 of 6)

WhenDealAmountParties
Mar 2017Secondary share transferUndisclosedBuyer: Curia Global Holdings Limited
Seller: Albany Molecular Research Inc, Curia Mauritius Private Limited
Mar 2012Funding round₹2.3 CrInvestors: Curia Mauritius Private Limited
Mar 2010Funding round₹15.04 CrInvestors: Curia Mauritius Private Limited
Jan 2008Secondary share transferUndisclosedBuyer: Curia Mauritius Private Limited, Albany Molecular Research Inc
Seller: Albany Molecular Research Inc & Hiroo Hotchand Adwani
Jul 2006Funding round₹7.83 CrInvestors: Curia Mauritius Private Limited

To see the full deal history of Curia India Private Limited, buy the company report.

Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.

MSME payment delays

Curia India Private Limited has 13 MSME Form 1 returns on record between 2019 and 2023, listing 1,941 overdue payments to 136 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.

Suppliers with reported dues (5 of 136)

SupplierAmount dueDue sinceReported on
Srikar Laboratories Private Limited
Bharat Science Apparatus Workshops
Lakshmi Venkateshwara Enterprises
Informa Markets India Private Limited
Pci Pest Control Private Limited

To see the full MSME payment records of Curia India Private Limited, buy the company report.

Individuals and sole proprietors among the suppliers are not named.

Employees & EPFO

Curia India Private Limited has a workforce of 11 employees on its EPFO records as of Apr 02, 2024, across 1 active EPFO establishment.

Employee count
11
Active EPFO establishments
1

GST

Curia India has 4 GST registrations: 3 active and 1 cancelled or inactive.

Total GSTINs
4
Active
3
Cancelled / inactive
1
GSTINStateStatusRegistered on
36AAFCA1469D1ZXTelanganaActive01 Jul 2017
36AAFCA1469D2ZWTelanganaActive01 Jul 2024
27AAFCA1469D1ZWMaharashtraActive06 Nov 2018

To see the full GST registrations and return filing status of Curia India Private Limited, buy the company report.

Recent activity

Curia India Private Limited has 27 board changes on record since 2007: 6 appointments and 21 cessations. The latest: Satyanarayana Tummanapalli was appointed as Whole-Time Director on 18 Sep 2025.

AGM
Curia India Private Limited last Annual general meeting of members was held on 29 Sep 2025 as per latest MCA records.
Appointed
Satyanarayana Tummanapalli was appointed as Whole-Time Director.
Filing
Curia India Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Hyderabad.
Appointed
Manoj Deo Dorlikar was appointed as Whole-Time Director.
Ceased
Abhinav Arora ceased to be Whole-Time Director.
Ceased
James Francis Grabowski Jr ceased to be Additional Director.
Ceased
Gudaparthi Omprakash ceased to be Whole-Time Director.
Appointed
James Francis Grabowski Jr was appointed as Director.
Ceased
Mariesa Beth Coppola ceased to be Additional Director.
Ceased
Anand Kumar Jain ceased to be Director.
Appointed
Subir Kumar Sadhukhan was appointed as Whole-Time Director.
Ceased
Anurag Rastranayaka ceased to be Company Secretary.

22 earlier events are in the company report.

Frequently asked questions

Curia India is an active private limited company based in Hyderabad, Telangana, India. The company works in pharma contract r and d, within the pharma industry. It was incorporated on 25 January 2005 (21+ years old) and is registered under CIN U73200TG2005PTC045178.

Curia India has 5 current directors:

The latest financial statements of Curia India on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 29 September 2025. Year-wise statements from 2015 are in the company report.

The GSTIN of Curia India is 36AAFCA1469D1ZX, registered in Telangana. The company has 4 GST registrations in all, of which 3 are active and 1 is cancelled or inactive. Other active GSTINs include 36AAFCA1469D2ZW (Telangana), 27AAFCA1469D1ZW (Maharashtra).

The CIN (Corporate Identification Number) of Curia India is U73200TG2005PTC045178. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Curia India has 4 court cases on record: 1 filed by the company and 3 filed against it. 4 are pending. Most are in the high courts.

Curia India was incorporated on 25 January 2005, making it 21+ years old. It is registered with the Registrar of Companies, Hyderabad.

Curia India has 6 deals on record (4 funding rounds, 2 secondary share transfers), with disclosed funding of ₹25.61 Cr; the latest was in March 2017.

Satyanarayana Tummanapalli was appointed as Whole-Time Director on 18 Sep 2025. Manoj Deo Dorlikar was appointed as Whole-Time Director on 12 Jul 2023. Abhinav Arora ceased to be Whole-Time Director on 01 Jul 2023. Curia India has 27 board changes on record in total.

Curia India has 13 MSME Form 1 returns on record between 2019 and 2023, listing 1,941 overdue payments to 136 micro and small suppliers. The latest return was filed on 18 Dec 2023.

Curia India can be reached through the website curiaglobal.com. Its registered office is in Hyderabad, Telangana, India.